Adjuvant Chemotherapy in Endometrial Carcinoma: Overview of Randomised Trials

Clinical Oncology

Volumn 20, Issue 6, 2008, Pages 463-469

  Hogberg, T ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adjuvant; chemotherapy; endometrial; micrometastatic

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ABDOMINAL HYSTERECTOMY; ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT THERAPY; ADVANCED CANCER; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BONE MARROW TOXICITY; CANCER ADJUVANT THERAPY; CANCER STAGING; CARDIOTOXICITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CYSTITIS; DIARRHEA; DRUG FATALITY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDOMETRIUM CARCINOMA; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL TOXICITY; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTESTINE OBSTRUCTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER; SALPINGOOOPHORECTOMY; SIDE EFFECT; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL; TREATMENT OUTCOME;

EID: 46149123209     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.04.001     Document Type: Article

References (21)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
2. The National Board of Health and Welfare Centre for Epidemiology. Cancer incidence in Sweden 2006. Available from:. http://www.socialstyrelsen.se/Statistik/statistik_amne/Cancer
3. Creasman W.T., Odicino F., Maisonneuve P., et al. Carcinoma of the corpus uteri. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 95 Suppl 1 (2006) S105-S143
4. Humber C.E., Tierney J.F., Symonds R.P., et al. Chemotherapy for advanced, recurrent or metastatic endometrial cancer: a systematic review of Cochrane collaboration. Ann Oncol 18 3 (2007) 409-420
5. Aapro M.S., van Wijk F.H., Bolis G., et al. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol 14 3 (2003) 441-448
6. Thigpen J.T., Brady M.F., Homesley H.D., et al. Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 22 19 (2004) 3902-3908
7. Fleming G.F., Brunetto V.L., Cella D., et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 22 11 (2004) 2159-2166
8. Sorbe B, Andersson H, Boman K, Rosenberg P, Kalling M. Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up. Int J Gynecol Cancer, in press. doi:10.1111/j.1525-1438.2007.01094.x.
9. National Cancer Institute. GOG-209. Available from:. http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=305940&protocolsearchid=4206096&version=healthprofessional
10. Randall M.E., Filiaci V.L., Muss H., et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 24 1 (2006) 36-44
11. McMeekin D.S., Filiaci V.L., Thigpen J.T., Gallion H.H., Fleming G.F., and Rodgers W.H. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study. Gynecol Oncol 106 1 (2007) 16-22
12. Morrow C.P., Bundy B.N., Homesley H.D., et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group study. Gynecol Oncol 36 2 (1990) 166-171
13. Maggi R., Lissoni A., Spina F., et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95 3 (2006) 266-271
14. Susumu N., Sagae S., Udagawa Y., et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 108 (2008) 226-233
15. Hogberg T., Rosenberg P., Kristensen G., et al. A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). J Clin Oncol 25 18S (2007) [abstract 5503]
16. Greven K., Winter K., Underhill K., Fontenesci J., and Burke T. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103 1 (2006) 155-159
17. National Cancer Institute. PORTEC 3. Available from:. http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=521447&protocolsearchid=4206096&version=healthprofessional
18. Dell'Anna T., Buda A., and Floriani I. Adjuvant chemotherapy for endometrial cancer. The Cochrane Library Available from: (2008). http://www.thecochranelibrary.com
19. Zee B.C. Planned equivalence or noninferiority trials versus unplanned noninferiority claims: are they equal?. J Clin Oncol 24 7 (2006) 1026-1028
20. Orton J., and Blake P. Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: results of the randomised MRC ASTEC and NCIC CTG EN.5 trial. J Clin Oncol 25 18S (2007) [abstract 5504]
21. Hogberg T., Glimelius B., and Nygren P. A systematic overview of chemotherapy effects in ovarian cancer. Acta Oncol 40 2-3 (2001) 340-360